Innovators at NASA’s Johnson Space Center (JSC) have patented an apparatus and method to treat atherosclerosis. The technology repairs diseased coronary arteries during cardiac catheterization by delivering microwave energy (3-300 gigahertz for less than a second) to precise artery locations to selectively target and heat atherosclerotic lesions while preserving the most superficial endothelial cell layer. Preservation of the endothelium cell layer is especially important for preventing thrombotic, inflammatory, and proliferative processes that complicate angioplastic procedures. The temperature profile can be customized to the size, shape, and type of lesion being treated. JSC has received patent number 6,496,736 for this technology.
Johnson Space Center has received patent protection (U.S. 6,496,736→) for this technology.
This technology is being made available through JSC’s Technology Transfer and Commercialization Office, which seeks to transfer technology into and out of NASA to benefit the space program and U.S. industry. NASA invites companies to consider licensing this technology for commercial applications.
If you would like more information about this technology or about NASA’s technology transfer program, please contact:Technology Transfer and Commercialization Office